Based on our Pharmacor advisory service entitled Rheumatoid Arthritis, Decision Resources is offering an exclusive Pharmacor analyst call entitled Rheumatoid Arthritis: Will Actemra Ultimately Steal Market Share from the TNF-Alpha Inhibitors? Because this analyst call features major updates, it is ONLY available to purchasers this Pharmacor advisory service.

 

This analyst call was held on February 10, 2010. Contact us to learn how you can purchase this Pharmacor advisory service and access a recorded playback of this event.

Click here to view the invite.